Blog
Promotional image for Net-A-Porter premier delivery service Online marketplace Amazon may be in talks to purchase British ecommerce site Net-A-Porter, if reports that have been rumored are true. The etail giant has been unsuccessful in entering the luxury industry in spite of attempts in recent years, and this potential acquisition could be significant for the future of both companies. The impact that this purchase could have on Net-A-Porter is unclear,
[Business Wire] – The following statement is being issued by Levi & Korsinsky, LLP:
[Business Wire] – Hecla Mining Company and Revett Mining Company, Inc. today announced that they have entered into a merger agreement pursuant to which Hecla will acquire Revett.
NEW YORK (TheStreet) — Gold opened flat when trading began in New York on Wednesday evening. Then starting just before 9 a.m. Hong Kong time, a rally began that grew stronger as the Far East trading session unfolded. It was up a decent amount by the London open—and then went vertical at 8:00 a.m. GMT, but ran into the usual not-for-profit sellers less than fifteen minutes later—and by 9 a.m.
As people continue to digest breaking news from around the world, today the Godfather of newsletter writers, 90-year-old Richard Russell, covers everything from China, the IMF and World Bank, to gold, blood in the streets and a world in turmoil.
On a day when the dollar, gold and crude oil all rallied, today one of the greats in the business sent King World News a powerful piece discussing the wild trading in global markets and where we’re headed from here.
WASHINGTON (Reuters) – A U.S. patient being treated for the Ebola virus at a National Institutes of Health facility in Maryland has improved to serious condition from critical, the NIH said on Thursday. (Reporting by Emily Stephenson; Editing by Lisa Lambert)
FRANKFURT (Reuters) – Morphosys and Celgene have agreed to end their cooperation on MOR202, but clinical trials of the drug candidate will continue, Morphosys said on Thursday. Morphosys said it aimed to release first clinical data from the ongoing phase 1/2a trial at a medical conference in 2015. It also raised its 2015 profit guidance, saying it expected to post 2015 earnings before interest and tax (EBIT) of between 9
